Welcome to the Hope Bio Blog

Inspired by results in other autoimmune conditions By Jan Shultis, Ph.D. Billions of stem cells manufactured through proprietary technology by Houston-area biotechnology company Hope Biosciences have the regulatory “green light” to join the fight against Crohn’s Disease. The U.S. Food and Drug Administration (FDA) has authorized a Phase II clinical trial to evaluate whether the stem cells manufactured through Hope’s proprietary technology affect signs and symptoms of Crohn’

By Jan Shultis, Ph.D. Billions of stem cells manufactured through proprietary technology by Houston-area biotechnology company Hope Biosciences are soon to be pressed into the fight against Alzheimer’s Disease (AD). The U.S. Food and Drug Administration (FDA) has authorized an open label Phase Ib/IIa clinical trial to evaluate whether Hope Biosciences autologous, adipose-derived mesenchymal stem cells (HB-adMSCs) reduce inflammation in the brain, improve brain activity, and

By Jan Shultis, Ph.D. About six months ago, did you resolve that this would be a new year, and a new "you"? As summer proceeds and coaches in seemingly every field start to ask how we're doing with those resolutions set back in January, maybe it's time for a pivot - what about “new year, same you,” but “now healthier and optimally protected against threats like degenerative disease or catastrophic illness?” If that resonates, welcome to Hope Biosciences, at any time of year!